By Professor David Lawson Morris

Journal articles

Saxena A; Valle SJ; Liauw W; Morris DL, 2017, 'Recurrence and survival outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for small bowel adenocarcinoma', Anticancer Research, 37, pp. 5737 - 5742, http://dx.doi.org/10.21873/anticanres.12012

Pardo F; Sangro B; Lee RC; Manas D; Jeyarajah R; Donckier V; Maleux G; Pinna AD; Bester L; Morris DL; Iannitti D; Chow PK; Stubbs R; Gow PJ; Masi G; Fisher KT; Lau WY; Kouladouros K; Katsanos G; Ercolani G; Rotellar F; Bilbao JI; Schoen M, 2017, 'The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres', Annals of Surgical Oncology, 24, pp. 2465 - 2473, http://dx.doi.org/10.1245/s10434-017-5950-z

Saxena A; Valle SJ; Liauw W; Morris DL, 2017, 'Allogenic Blood Transfusion Is an Independent Predictor of Poorer Peri-operative Outcomes and Reduced Long-Term Survival after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a Review of 936 Cases', Journal of Gastrointestinal Surgery, 21, pp. 1318 - 1327, http://dx.doi.org/10.1007/s11605-017-3444-8

Saxena A; Liauw W; Morris DL, 2017, 'Splenectomy is an independent risk factor for poorer perioperative outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An analysis of 936 procedures', Journal of Gastrointestinal Oncology, 8, pp. 737 - 746, http://dx.doi.org/10.21037/jgo.2017.07.09

Pillai K; Akhter J; Morris DL, 2017, 'Assessment of a novel mucolytic solution for dissolving mucus in pseudomyxoma peritonei: An ex vivo and in vitro study', Pleura and Peritoneum, 2, pp. 111 - 117, http://dx.doi.org/10.1515/pp-2017-0013

Huang Y; Alzahrani NA; Chua TC; Liauw W; Morris DL, 2017, 'Repeat cytoreductive surgery with or without perioperative intraperitoneal chemotherapy for peritoneal surface malignancy', American Journal of Surgery, 213, pp. 1024 - 1030, http://dx.doi.org/10.1016/j.amjsurg.2016.09.046

Huo YR; Phan K; Morris DL; Liauw W, 2017, 'Systematic review and a meta-analysis of hospital and surgeon volume/outcome relationships in colorectal cancer surgery', Journal of Gastrointestinal Oncology, 8, pp. 534 - 546, http://dx.doi.org/10.21037/jgo.2017.01.25

Kozman MA; Fisher OM; Valle SJ; Alzahrani N; Morris DL, 2017, 'The use of carbon dioxide insufflation to facilitate identification of intestinal injuries in patients undergoing cytoreductive surgery and intraperitoneal chemotherapy', Techniques in Coloproctology, 21, pp. 479 - 480, http://dx.doi.org/10.1007/s10151-017-1644-6

Mamoori A; Gopalan V; Lu CT; Chua TC; Morris DL; Smith RA; Lam AKY, 2017, 'Expression pattern of miR-451 and its target MIF (macrophage migration inhibitory factor) in colorectal cancer', Journal of clinical pathology, 70, pp. 308 - 312, http://dx.doi.org/10.1136/jclinpath-2016-203972

Huang Y; Alzahrani NA; Chua TC; Morris DL, 2017, 'Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients with Appendiceal Mucinous Neoplasm with Peritoneal Dissemination', Diseases of the Colon and Rectum, 60, pp. 360 - 367, http://dx.doi.org/10.1097/DCR.0000000000000719

Saxena A; Valle SJ; Liauw W; Morris DL, 2017, 'Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy', Journal of Surgical Oncology, 115, pp. 417 - 424, http://dx.doi.org/10.1002/jso.24543

Kyang LS; Alzahrani NA; Zhao J; Morris DL, 2017, 'Gastric perforation following cytoreductive surgery and perioperative intraperitoneal chemotherapy: A case series of six', World Journal of Surgical Oncology, 15, pp. 44, http://dx.doi.org/10.1186/s12957-017-1114-7

Masoumi-Moghaddam S; Amini A; Morris DL, 2017, 'Is mucin a determinant of peritoneal dissemination of gastrointestinal cancer? Analysis of mucin depletion in two preclinical models', Clinical and Translational Oncology, 19, pp. 261 - 264, http://dx.doi.org/10.1007/s12094-016-1519-8

Huang Y; Alzahrani NA; Liauw W; Traiki TB; Morris DL, 2017, 'Early Postoperative Intraperitoneal Chemotherapy for Low-Grade Appendiceal Mucinous Neoplasms with Pseudomyxoma Peritonei: Is it Beneficial?', Annals of Surgical Oncology, 24, pp. 176 - 183, http://dx.doi.org/10.1245/s10434-016-5529-0

Huo YR; Glenn D; Liauw W; Power M; Zhao J; Morris DL, 2017, 'Evaluation of carcinoembryonic antigen (CEA) density as a prognostic factor for percutaneous ablation of pulmonary colorectal metastases', European Radiology, 27, pp. 128 - 137, http://dx.doi.org/10.1007/s00330-016-4352-0

Huang Y; Alzahrani NA; Liauw W; Morris DL, 2017, 'Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis', ANZ Journal of Surgery, 87, pp. 49 - 54, http://dx.doi.org/10.1111/ans.13280

Suh H; Pillai K; Morris DL, 2017, 'Mucins in pancreatic cancer: Biological role, implications in carcinogenesis and applications in diagnosis and therapy', American Journal of Cancer Research, 7, pp. 1372 - 1383

Leung V; Huo YR; Liauw W; Morris DL, 2017, 'Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis', European Journal of Surgical Oncology, 43, pp. 144 - 149, http://dx.doi.org/10.1016/j.ejso.2016.09.015

Pillai K; Akhter J; Mekkawy A; Chua TC; Morris DL, 2017, 'Physical and chemical characteristics of mucin secreted by pseudomyxoma peritonei (PMP)', International Journal of Medical Sciences, 14, pp. 18 - 28, http://dx.doi.org/10.7150/ijms.16422

Pillai K; Akhter J; Morris DL, 2017, 'Super Aqueous Solubility of Albendazole in β-Cyclodextrin for Parenteral Application in Cancer therapy', Journal of Cancer, 8, pp. 913 - 923, http://dx.doi.org/10.7150/jca.17301

Suh H; Valle S; Morris DL, 2017, 'Targeting MUC16 in Cancer Therapy', Chemotherapy: Open Access, 06, http://dx.doi.org/10.4172/2167-7700.1000235

Alzahrani N; Ferguson JS; Valle SJ; Liauw W; Chua T; Morris DL, 2016, 'Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St George Hospital, Australia', ANZ Journal of Surgery, 86, pp. 937 - 941, http://dx.doi.org/10.1111/ans.13152

Valle SJ; Alzahrani N; Alzahrani S; Traiki TB; Liauw W; Morris DL, 2016, 'Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes', Surgical Oncology, 25, pp. 315 - 320, http://dx.doi.org/10.1016/j.suronc.2016.05.025

Yonemura Y; Canbay E; Li Y; Coccolini F; Glehen O; Sugarbaker PH; Morris D; Moran B; Gonzaletz-Moreno S; Deraco M; Piso P; Elias D; Batlett D; Ishibashi H; Mizumoto A; Verwaal V; Mahtem H, 2016, 'A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent', European Journal of Surgical Oncology, 42, pp. 1123 - 1131, http://dx.doi.org/10.1016/j.ejso.2016.03.016

Huang Y; Alzahrani NA; Chua TC; Liauw W; Morris DL, 2016, 'Impacts of peritoneal cancer index on the survival outcomes of patients with colorectal peritoneal carcinomatosis', International Journal of Surgery, 32, pp. 65 - 70, http://dx.doi.org/10.1016/j.ijsu.2016.06.033

Huang Y; Alzahrani NA; Chua TC; Huo YR; Liauw W; Morris DL, 2016, 'Impacts of Preoperative Serum Albumin Level on Outcomes of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy', Annals of Surgical Oncology, 23, pp. 2411 - 2418, http://dx.doi.org/10.1245/s10434-016-5172-9

Doyle M; Villanueva C; Davies S; Fermanis G; Horton M; Morris D, 2016, 'Cytoreductive surgery and heated intrathoracic chemotherapy for thoracic extension of Pseudomyxoma peritonei', Integrative Cancer Science and Therapeutics, 3, pp. 504 - 508, http://dx.doi.org/10.15761/ICST.1000198

Lansom J; Alzahrani N; Liauw W; Morris DL, 2016, 'Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours', Indian Journal of Surgical Oncology, 7, pp. 166 - 176, http://dx.doi.org/10.1007/s13193-015-0478-9

Leung V; Huang N; Liauw W; Morris DL, 2016, 'High risk features of primary colorectal carcinomas which subsequently undergo peritonectomy', European Journal of Surgical Oncology, 42, pp. 836 - 840, http://dx.doi.org/10.1016/j.ejso.2015.08.161

Valle SJ; Alzahrani NA; Liauw W; Sugarbaker PH; Bhatt A; Morris DL, 2016, 'Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional Chemotherapy', Indian Journal of Surgical Oncology, 7, pp. 152 - 159, http://dx.doi.org/10.1007/s13193-016-0498-0

Jiang Y; Lu H; Chen F; Callari M; Pourgholami M; Morris DL; Stenzel MH, 2016, 'PEGylated Albumin-Based Polyion Complex Micelles for Protein Delivery', Biomacromolecules, 17, pp. 808 - 817, http://dx.doi.org/10.1021/acs.biomac.5b01537

Huang Y; Alzahrani NA; Chua TC; Huo YR; Morris DL, 2016, 'Clinical outcomes of patients with extensive peritoneal carcinomatosis following cytoreductive surgery and perioperative intraperitoneal chemotherapy', Anticancer Research, 36, pp. 1033 - 1040

Huo YR; Huang Y; Liauw W; Zhao J; Morris DL, 2016, 'Prognostic value of carcinoembryonic antigen (cea), afp, ca19-9 and ca125 for patients with colorectal cancer with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy', Anticancer Research, 36, pp. 1041 - 1050

Huo YR; Pillai K; Akhter J; Morris DL, 2016, '“Edgeboost”: A Novel Technique to Extend the Ablation Zone Lateral to a Two-Probe Bipolar Radiofrequency Device', CardioVascular and Interventional Radiology, 39, pp. 97 - 105, http://dx.doi.org/10.1007/s00270-015-1168-2

Schwarz L; Votanopoulos K; Morris D; Yonemura Y; Deraco M; Piso P; Moran B; Levine EA; Tuech JJ, 2016, 'Is the combination of distal pancreatectomy and cytoreductive surgery with HIPEC reasonable? results of an international multicenter study', Annals of Surgery, 263, pp. 369 - 375, http://dx.doi.org/10.1097/SLA.0000000000001225

Kyang LS; Bin Traiki TA; Alzahrani NA; Morris DL, 2016, 'Microwave ablation of liver metastasis complicated by Clostridium perfringens gas-forming pyogenic liver abscess (GPLA) in a patient with past gastrectomy', International Journal of Surgery Case Reports, 27, pp. 32 - 35, http://dx.doi.org/10.1016/j.ijscr.2016.08.009

Amini A; Masoumi-Moghaddam S; Ehteda A; Liauw W; Morris DL, 2016, 'Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: Sequential and combination therapy of gastrointestinal cancer cells', American Journal of Cancer Research, 6, pp. 350 - 369

Huo Y; Glenn D; Power M; Zhao J; Liauw W; Morris D, 2016, 'CEA failure as a prognostic factor for percutaneous ablation of pulmonary colorectal metastases', Journal of Vascular and Interventional Radiology, 27, pp. S82 - S82, http://dx.doi.org/10.1016/j.jvir.2015.12.218

Huo Y; Glenn D; Power M; Zhao J; Liauw W; Morris D, 2016, 'Evaluation of CEA density as a prognostic factor for percutaneous ablation of pulmonary colorectal metastases', Journal of Vascular and Interventional Radiology, 27, pp. S123 - S123, http://dx.doi.org/10.1016/j.jvir.2015.12.323

Huo Y; Glenn D; Power M; Zhao J; Liauw W; Morris D, 2016, 'Incidence of and risk factors for pneumothorax and other complications following percutaneous ablation of lung metastases: a single-centre experience of 312 sessions', Journal of Vascular and Interventional Radiology, 27, pp. S81 - S82, http://dx.doi.org/10.1016/j.jvir.2015.12.217

Morris DL, 2016, 'Peer review report 1 on “The effect of Laparoscopic Sleeve Gastrectomy (LSG) on glycemic control in morbidly obese patients”', International Journal of Surgery, 25, pp. 151 - 151, http://dx.doi.org/10.1016/j.ijsu.2016.02.074

Huo YR; Richards A; Liauw W; Morris DL, 2015, 'Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: A systematic review and meta-analysis', European Journal of Surgical Oncology, 41, pp. 1578 - 1589, http://dx.doi.org/10.1016/j.ejso.2015.08.172

Huang Y; Alzahrani NA; Liauw W; Morris DL, 2015, 'Repeat cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent diffuse malignant peritoneal mesothelioma', European Journal of Surgical Oncology, 41, pp. 1373 - 1378, http://dx.doi.org/10.1016/j.ejso.2015.07.004

Masoumi-Moghaddam S; Amini A; Wei A; Robertson G; Morris DL, 2015, 'VEGF EXPRESSION: A USEFUL TOOL IN PREDICTION OF REFRACTORINESS TO PLATINUM-BASED CHEMOTHERAPY AND ASCITES FORMATION IN EPITHELIAL OVARIAN CANCER', INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 25, pp. 1436 - 1436

Chan DL; Alzahrani NA; Morris DL; Chua TC, 2015, 'Systematic review and meta-analysis of hepatic arterial infusion chemotherapy as bridging therapy for colorectal liver metastases', Surgical Oncology, 24, pp. 162 - 171, http://dx.doi.org/10.1016/j.suronc.2015.06.014

Huang Y; Alzahrani NA; Alzahrani SE; Zhao J; Liauw W; Morris DL, 2015, 'Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly', World Journal of Surgical Oncology, 13, http://dx.doi.org/10.1186/s12957-015-0682-7

Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL, 2015, 'Intratumoral interleukin-6 predicts ascites formation in patients with epithelial ovarian cancer: A potential tool for close monitoring', Journal of Ovarian Research, 8, http://dx.doi.org/10.1186/s13048-015-0183-x

Pillai K; Pourgholami MH; Chua TC; Morris DL, 2015, 'Prognostic Significance of Ki67 Expression in Malignant Peritoneal Mesothelioma', American Journal of Clinical Oncology: Cancer Clinical Trials, 38, pp. 388 - 394, http://dx.doi.org/10.1097/COC.0b013e3182a0e867

Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL, 2015, 'Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer', International Journal of Cancer, 137, pp. 560 - 570, http://dx.doi.org/10.1002/ijc.29425

Huang Y; Alzahrani NA; Liauw W; Morris DL, 2015, 'Effects of sex hormones on survival of peritoneal mesothelioma', World Journal of Surgical Oncology, http://dx.doi.org/10.1186/s12957-015-0624-4

Back to profile page